At the end of ever year, to much fanfare, we present the Dermie awards! Here are this 2022's categories, nominees, runners-up, and winners!
The Coolest Thing We Learned
- The Winner! Episode 93: Derm in spaaaace! Dunn C, Boyd M, Orengo I. Dermatologic manifestations in spaceflight: a review. Dermatol Online J. 2018 Nov. [article]
- Runner-up: Episode 90: Skeeter syndrome. Simons FE, Peng Z. Skeeter syndrome. J Allergy Clin Immunol. 1999 Sep. [article]
- Other nominees: Episode 85: Aplasia cutis and low risk of CNS disease. Kuemmet TJ, Miller JJ, Michalik D, Lew SM, Maheshwari M, Humphrey SR. Low risk of clinically important central nervous system dysraphism in a cohort study of 69 patients with isolated aplasia cutis congenita of the head. Pediatr Dermatol. 2020 May. [article]; Episode 90: Neutrophilic urticarial dermatosis. Gusdorf L, Lipsker D. Neutrophilic urticarial dermatosis: A review. Ann Dermatol Venereol. 2018 Dec. [article]
Most Zeitgeistian Article
- The Winner! Episode 81: Want an attractive face? Enlarge your eyes; shrink your nose and mouth. Przylipiak M, Przylipiak J, Terlikowski R, Lubowicka E, Chrostek L, Przylipiak A. Impact of face proportions on face attractiveness. J Cosmet Dermatol. 2018 Dec . [article]
- Runner-up: Episode 78: People don't like how they look on Zoom - with Dr. Kim Nichols! Pikoos TD, Buzwell S, Sharp G, Rossell SL. The Zoom Effect: Exploring the Impact of Video Calling on Appearance Dissatisfaction and Interest in Aesthetic Treatment During the COVID-19 Pandemic. Aesthet Surg J. 2021. [article]
- Other nominees: Episode 70: Covid boosters: Mix and match for victory! Munro APS, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021 Dec. [article] Episode 76: Nicotinamide for NMSC prophylaxis. Mainville L, Smilga AS, Fortin PR. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis. J Cutan Med Surg. 2022 May-Jun. [article]
Coolest Author Name
- The Winners! Agatha van der Klaauw, Matthew Snape, and Saul Faust from Episode 70: Covid boosters: Mix and match for victory! Munro APS, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021 Dec. [article]
- Runner-up: Dawn Queen from Episode 74: Patients like young, prompt dermatologists. Trager MH, Queen D, Fan W, Samie FH. Patient Satisfaction of General Dermatologists: A Quantitative and Qualitative Analysis of 38,008 Online Reviews by Gender and Years of Experience. JID Innov. 2021 Dec. [article]
- Other nominee: Emilia Lubowicka from Episode 81: Want an attractive face? Enlarge your eyes; shrink your nose and mouth. Przylipiak M, Przylipiak J, Terlikowski R, Lubowicka E, Chrostek L, Przylipiak A. Impact of face proportions on face attractiveness. J Cosmet Dermatol. 2018 Dec. [article]
Most Intellectually Interesting Article
- The Winner! Episode 76: Fibroblasts and AD. Ko KI et al. NF-κB perturbation reveals unique immunomodulatory functions in Prx1+ fibroblasts that promote development of atopic dermatitis. Sci Transl Med. 2022 Feb. [article]
- Runner-up: Episode 72: Find your Muse cells... for atopic dermatitis. Fei W, Wu J, Gao M, Wang Q, Zhao YY, Shan C, Shen Y, Chen G. Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice. Stem Cell Res Ther. 2021 Dec. [article]
- Other nominees: Episode 78: Bile acids inhibit IL-17. Shi Z, Wu X, Wu CY, Singh SP, Law T, Yamada D, Huynh M, Liakos W, Yang G, Farber JM, Wan YY, Hwang ST. Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6-Mediated Trafficking of T Cells. J Invest Dermatol. 2022 May. [article] Episode 88: AKs-> SCC? Ahmady S, Jansen MHE, Nelemans PJ, Kessels JPHM, Arits AHMM, de Rooij MJM, Essers BAB, Quaedvlieg PJF, Kelleners-Smeets NWJ, Mosterd K. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial. JAMA Dermatol. 2022 Jun. [article]
Coolest Image(I don't think we can actually include them due to copyright issues, but follow the links to check them out!)
- The Winner! Episode 75: Trichoscopy. Kinoshita-Ise M, Sachdeva M. Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart. J Dermatol. 2022 Jan. [article]
- Runner-up: Episode 83: Longitudinal melanonychia in kids. Lee JH, Lim Y, Park JH, Lee JH, Jang KT, Kwon EJ, Lee DY. Clinicopathologic features of 28 cases of nail matrix nevi (NMNs) in Asians: Comparison between children and adults. J Am Acad Dermatol. 2018 Mar. [article]
- Other nominees: Episode 91: Child abuse mimics. Bentivegna K, Grant-Kels JM, Livingston N. Cutaneous mimics of child abuse and neglect: Part II. J Am Acad Dermatol. 2022 Sep. [article] Episode 92: Pruritic and dyskeratotic dermatoses. Nguyen KD, Lee EE, Yue Y, Stork J, Pock L, North JP, Vandergriff T, Cockerell C, Hosler GA, Pastrana DV, Buck CB, Wang RC. Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses. J Am Acad Dermatol. 2017 May. [article]
Grossest Image (As above re: copyright issues)
- The Winner! Episode 94: Xylazine-induced ulcers. Malayala SV, Papudesi BN, Bobb R, Wimbush A. Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA. Cureus. 2022 Aug. [article]
- Runner-up: Episode 91: Bullous hemorrhagic dermatitis. Uceda-Martin M, Lambert A, Miremont G, Gaiffe A, Agier MS, Studer M, Mahé A, Tebacher M, Cribier B. Bullous haemorrhagic dermatitis induced by heparins and other anticoagulants: 94 cases from French pharmacovigilance centres and a literature review. Ann Dermatol Venereol. 2022 Mar. [article]
- Other nominee: Episode 72: Trichodysplasia spinulosa dermoscopy. Stonesifer CJ, Husain SA, Niedt GW, Gallitano SM. Dermatoscopy case of the month: Trichodysplasia spinulosa. JAAD Case Rep. 2021 Sep. [article]
Most Pimpable Article
- The Winner! Episode 73: Shawn Kwatra's CME articles about pruritus. Roh YS, Choi J, Sutaria N, Kwatra SG. Itch: Epidemiology, clinical presentation, and diagnostic workup. J Am Acad Dermatol. 2022 Jan . [article 1] & Sutaria N, Adawi W, Goldberg R, Roh YS, Choi J, Kwatra SG. Itch: Pathogenesis and treatment. J Am Acad Dermatol. 2022 Jan. [article 2]
- Runner-up: Episodes 72-76: Allergen alternatives. Scheman A, Hylwa-Deufel S, Jacob SE, Katta R, Nedorost S, Warshaw E, Eifrid K, Geiser AJ, McGaughey L, Scheman N, Kimyon R, Rundle C, Shaver R. Alternatives for Allergens in the 2018 American Contact Dermatitis Society Core Series: Report by the American Contact Alternatives Group. Dermatitis. 2019 Mar-Apr. [article]
- Other nominees: Episode 90: Cafe-au-lait screening. Albaghdadi M, Berseneva M, Pennal A, Wan S, Matviychuk D, Shugar A, Kannu P, Lara-Corrales I. Value of a café-au-lait macules screening clinic: Experience from The Hospital for Sick Children in Toronto. Pediatr Dermatol. 2022 Mar. [article] Episode 94: AESOP Syndrome. Lenormand C, Marzolf G, Lipsker D. AESOP syndrome: a potential life-saving and early clue to the diagnosis of POEMS syndrome. Clin Dermatol. 2021 Mar-Apr. [article]
Article Most Helpful in Daily Clinic
- The Winner! Episode 79: Suicidality decreases while on isotretinoin. Ugonabo N, Love E, Wong PW, Rieder EA, Orlow SJ, Kim RH, Nagler AR. Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: Analysis of a large commercial insurance claims database. J Am Acad Dermatol. 2021 Oct. [article]
- Runner-up: Episode 86: Isotretinoin lab monitoring guidelines. Xia E et al. Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study. JAMA Dermatol. 2022 Aug. [article]
- Other nominees: Episode 78: Timolol *does* work for hemangiomas? Wang X, Feng W, Zhao X, Liu Z, Dong L. The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials. Dermatology. 2021. [article] Episode 84: Terbinafine okay in liver disease. Wang Y, Geizhals S, Lipner SR. Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis. J Am Acad Dermatol. 2021 Feb. [article] Episode 86: Best systemic treatments for androgenetic alopecia. Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatol. 2022 Mar. [article]
Study I Wish I Had Thought of Myself
- The Winner! Episode 88: Isotretinoin lab monitoring is unnecessary. Affleck A, Jackson D, Williams HC, Chavez P, Albrecht J. Is routine laboratory testing in healthy young patients taking isotretinoin necessary: a critically appraised topic. Br J Dermatol. 2022 Dec. [article]
- Runner-up: Episode 92: VitD and PDT. Bullock TA, Negrey J, Hu B, Warren CB, Hasan T, Maytin EV. Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment: An interventional cohort-controlled trial. J Am Acad Dermatol. 2022 Jul. [article]
- Other nominees: Episode 72: Ketotifen + famotidine for melasma. Dias JAF, Lima PB, Cassiano DP, Espósito ACC, Bagatin E, Miot LDB, Miot HA. Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double-blind, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2022 Feb. [article] Episode 93: Congenital nevi and CNS abnormalities. Neale H, Plumptre I, Belazarian L, Wiss K, Hawryluk EB. Central nervous system magnetic resonance imaging abnormalities and neurologic outcomes in pediatric patients with congenital nevi: A 10-year multi-institutional retrospective study. J Am Acad Dermatol. 2022 Nov. [article]
Most Impactful Article
- The Winner! Episode 79: ORAL surveillance study of JAK risks. Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022 Jan. [article]
- Runner-up: Episode 89: Cutaneous manifestations of child abuse. Bentivegna K, Grant-Kels JM, Livingston N. Cutaneous manifestations of child abuse and neglect: Part I. J Am Acad Dermatol. 2022 Sep. [article]
- Other nominees: Episode 75: DRESS to autoimmune disease. Mizukawa Y, Aoyama Y, Takahashi H, Takahashi R, Shiohara T. Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification. J Invest Dermatol. 2022 Mar. [article] Episode 87: Baricitinib for AA. King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. Two Phase 3 Trials of Baricitinib for Alopecia Areata. N Engl J Med. 2022 May. [article]
Listeners' Choice
- The Winner! Episode 77: Update on: What is the best psoriasis biologic? Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M. Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. JAMA Dermatol. 2020 Mar. [article]
- Runners-up: Episode 73: Dupilumab vs abrocitinib for AD. Bieber T et al; JADE COMPARE Investigators. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis. N Engl J Med. 2021 Mar. [article] Episode 79: ORAL surveillance study of JAK risks. Ytterberg SR et al; ORAL Surveillance Investigators. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022 Jan. [article]
Best Overall
- The Winner! Episode 82: Discussion with Steve Feldman. [Dr. Feldman's book on adherence]
- Runner-up: Episode 72: NF1 affects income. Johansson E, Kallionpää RA, Böckerman P, Peltonen S, Peltonen J. The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland. Genet Med. 2022 Apr. [article]
- Other nominees: Episode 79: ORAL surveillance study of JAK risks. Ytterberg SR et al; ORAL Surveillance Investigators. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022 Jan. [article] Episode 79: Suicidality decreases while on isotretinoin. Ugonabo N, Love E, Wong PW, Rieder EA, Orlow SJ, Kim RH, Nagler AR. Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: Analysis of a large commercial insurance claims database. J Am Acad Dermatol. 2021 Oct. [article]